References
Weinstein MC. Recent developments in decision-analytic modelling for economic evaluation. Pharmacoeconomics 2006; 24 (11): 1043–1053
Claxton KP, Sculpher MJ. Using value of information analysis to prioritise health research: some lessons from recent UK experience. Pharmacoeconomics 2006; 24 (11): 1055–1068
Torrance GW. Utility measurement in healthcare: the things I never got to. Pharmacoeconomics 2006; 24 (11): 1069–1078
Briggs AH, Levy AR. Pharmacoeconomics and pharmacoepidemiology: curious bedfellows or a match made in heaven? Pharmacoeconomics 2006; 24 (11): 1079–1086
Sculpher MJ, Drummond MF. Analysis sans frontières: can we ever make economic evaluations generalisable across jurisdictions? Pharmacoeconomics 2006; 24 (11): 1087–1099
Manca A, Willan AR. ‘Lost in translation’: accounting for between-country differences in the analysis of multinational cost-effectiveness data. Pharmacoeconomics 2006; 24 (11): 1101–1119
Birch S, Gafni A. Information created to evade reality (ICER): things we should not look to for answers. Pharmacoeconomics 2006; 24 (11): 1121–1131
Buxton MJ. Economic evaluation and decision making in the UK. Pharmacoeconomics 2006; 24 (11): 1133–1143
Goeree R, Levin L. Building bridges between academic research and policy formulation: the PRUFE framework — an integral part of Ontario’s evidence-based HTPA process. Pharmacoeconomics 2006; 24 (11): 1145–1158
Laupacis A. Economic evaluations in the Canadian common drug review. Pharmacoeconomics 2006; 24 (11): 1159–1164
Neumann PJ, Sullivan SD. Economic evaluation in the US: what is the missing link? Pharmacoeconomics 2006; 24 (11): 1165–1170
Briggs A, Buxton M, Drummond MF, et al. Unfinished sympathy: a tribute to the life and career of Bernie O’Brien (1959–2004). Med Decis Making 2004; 24 (5): 538–544
Gold M, Seigel J, Russell L, et al. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996
National Institute for Health and Clinical Excellence (NICE). Guide to the methods of technology appraisal. London: NIC, 2004
Acknowledgements
We are grateful to all the speakers at the Conference, who so generously gave of their time. We are also grateful to Greg Stoddart and the other members of the Conference Organising Committee, without whose help and support this event would not have been possible.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Drummond, M.F., Sculpher, M.J. Better Analysis for Better Decisions. Pharmacoeconomics 24, 1039–1042 (2006). https://doi.org/10.2165/00019053-200624110-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-200624110-00001